DVAX250117C21000
- 0.00
- 0.000.00%
Dynavax Technologies Newsroom
Health Check: How Prudently Does Dynavax Technologies (NASDAQ:DVAX) Use Debt?
Dynavax Technologies (DVAX) Upgraded to Buy: Here's What You Should Know
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Raises Target Price to $31
Dynavax Is Maintained at Buy by HC Wainwright & Co.
Dynavax Technologies Analyst Ratings
Express News | Dynavax Technologies Corporation : H.c. Wainwright Raises Target Price to $31 From $29
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Awarded $30M Contract With U.S. Department of Defense >DVAX
Express News | Dynavax Technologies Corp: Heplisav-B Quarterly Net Product Revenue of $71 Mln
Express News | Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
Press Release: Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
$960 Mn Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine - Global Forecast to 2029 With GSK, Seppic, Croda, SPI Pharma, Phibro Animal Health, Agenus, Dynavax Technologies Dominating
Earnings Call Summary | Dynavax Technologies(DVAX.US) Q3 2024 Earnings Conference
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't?
US Manufacturing Index Rises To 43, Highest Since 2020
Dynavax Technologies Down Over 7%, On Track for Largest Percent Decrease Since August 2022 -- Data Talk
Express News | Dynavax Technologies Corp: Entered $100 Mln Accelerated Share Repurchase Agreement With Goldman Sachs & Co. LLC
Dynavax Technologies Corporation (NASDAQ:DVAX) Stock Catapults 31% Though Its Price And Business Still Lag The Industry
Dynavax: Will Have $100 Million Remaining Under Buyback Program >DVAX